Exhibitor

Rhegen Bio stands as a global leader in mRNA technology. The company has established a comprehensive platform across the entire mRNA value chain, amassing significant proprietary intellectual property. It has currently filed over 200 patents domestically and internationally, with a broad patent strategy that encompasses drug design, upstream mRNA, raw materials, mRNA design and synthesis, LNP delivery systems, formulation processes and industrial equipment for mRNA. The company has developed and released two group standards for mRNA. Leveraging these technological advancements and platforms, Rhegen accelerates the development of several innovative drugs aimed at infectious disease, cancer immunotherapy, metabolic disorders, and tissue repair.

Website:   https://www.rhegen.com/

« Go Back